← Back to Home
Swing·Markets Desk·Fri, 31 Jul
Multi-Day Momentum: BLUESTARCO Leads a 5-Stock Swing Watchlist
Nirmalbangofficial and Icms1 issued 5 swing trade recommendations targeting 2–5 day holding periods on bullish chart setups.
By Markets Desk·5 Calls·5 Buy
Nirmalbangofficial and 1 other registered desk issued 5 equity swing recommendations today, targeting price setups over a 2 to 5 day holding window. The batch carries a bullish bias — 5 buys against 0 sells — covering 5 stocks.
BLUESTARCO was flagged for a buy by Nirmalbangofficial at ₹1,707.4, targeting ₹1,765 — a potential upside of +3.4%, with a stoploss at ₹1,685. The risk-to-reward ratio stands at 1:2.6.
SYRMA was flagged for a buy by Icms1 at ₹1,389, targeting ₹1,465 — a potential upside of +5.5%, with a stoploss at ₹1,351. The risk-to-reward ratio stands at 1:2.0.
MRPL was flagged for a buy by Icms1 at ₹167.5, targeting ₹174.5 — a potential upside of +4.2%, with a stoploss at ₹164. The risk-to-reward ratio stands at 1:2.0.
Also covered: MOTHERSON (₹148.1 → ₹154.9) via Icms1; HSCL (₹775 → ₹803) via Icms1.
Swing positions are typically held for two to five sessions. Track broader index levels and avoid holding through major macro events without adjusting stoplosses.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
NirmalbangofficialIcms1
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.